Europe Bio Pharmaceuticals Market Distribution and Key Players Analysis to 2021

| November 6, 2017

article image
According to the report Europe Bio Pharmaceuticals Market, published by Market Data Forecast, the Europe market is projected to reach USD 56.83 billion by 2021, at a CAGR of 8.89% from 2016 to 2021. Primarily biopharmaceuticals products are obtained from life forms or genetically modified plants and animals known as transgenic organisms.

Spotlight

Advantia Health

Advantia Health is an innovative fast growing healthcare delivery company, founded and led by a passionate group of entrepreneurs and backed by top tier healthcare investors. Sean Glass, Founder & CEO of Advantia Health, previously founded and grew a financial technology company to more than a billion dollar valuation. Advantia Health provides high quality, high value care using technology and highly efficient outpatient facilities. In a little over three years, the company has grown to serve more than 100,000 customers and is on a path to serving many more in the years to come. Advantia’s investors include Deerfield Management, Life Force Capital, and individuals with significant health care, technology, and finance expertise.

OTHER ARTICLES

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 6, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Spotlight

Advantia Health

Advantia Health is an innovative fast growing healthcare delivery company, founded and led by a passionate group of entrepreneurs and backed by top tier healthcare investors. Sean Glass, Founder & CEO of Advantia Health, previously founded and grew a financial technology company to more than a billion dollar valuation. Advantia Health provides high quality, high value care using technology and highly efficient outpatient facilities. In a little over three years, the company has grown to serve more than 100,000 customers and is on a path to serving many more in the years to come. Advantia’s investors include Deerfield Management, Life Force Capital, and individuals with significant health care, technology, and finance expertise.

Events